150 related articles for article (PubMed ID: 37970573)
1. Pulmonary hypertension in adults completing tuberculosis treatment.
Allwood BW; Manie S; Stolbrink M; Hunter L; Matthee S; Meintjes G; Amosun SL; Pecoraro A; Walzl G; Irusen E
Afr J Thorac Crit Care Med; 2023; 29(3):. PubMed ID: 37970573
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients.
Louw E; Baines N; Maarman G; Osman M; Sigwadhi L; Irusen E; Koegelenberg C; Doubell A; Nathan S; Channick R; Allwood B
Pulm Circ; 2023 Jan; 13(1):e12184. PubMed ID: 36699148
[TBL] [Abstract][Full Text] [Related]
3. Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD).
Shaw JG; Dent AG; Passmore LH; Burstow DJ; Bowman RV; Zimmerman PV; Fong KM; Yang IA
BMC Pulm Med; 2012 Jun; 12():25. PubMed ID: 22695028
[TBL] [Abstract][Full Text] [Related]
4. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey.
Xing Z; Sun T; Janssens JP; Chai D; Liu W; Tong Y; Wang Y; Ma Y; Pan M; Cui J; Wang C; Guo Y
Thorax; 2023 Mar; 78(3):274-280. PubMed ID: 35361688
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension as seen in a rural area in sub-Saharan Africa: high prevalence, late clinical presentation and a high short-term mortality rate during follow up.
Dzudie A; Dzekem BS; Tchoumi CT; Aminde LN; Mocumbi AO; Abanda M; Thienemann F; Kengne AP; Sliwa K
Cardiovasc J Afr; 2018 Jul/Aug 23; 29(4):208-212. PubMed ID: 30059129
[TBL] [Abstract][Full Text] [Related]
6. Lung function and collagen 1a levels are associated with changes in 6 min walk test distance during treatment of TB among HIV-infected adults: a prospective cohort study.
Baik Y; Maenetje P; Schramm D; Tiemessen C; Ncube I; Churchyard G; Wallis R; Vangu MD; Kornfeld H; Li Y; Auld SC; Bisson GP
BMC Pulm Med; 2023 Feb; 23(1):53. PubMed ID: 36737697
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.
Nathan SD; Shlobin OA; Barnett SD; Saggar R; Belperio JA; Ross DJ; Ahmad S; Saggar R; Libre E; Lynch JP; Zisman DA
Respir Med; 2008 Sep; 102(9):1305-10. PubMed ID: 18619825
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Occult pulmonary arterial hypertension in patients with previous pulmonary tuberculosis.
Kalla IS; Miri A; Seedat F
Afr J Thorac Crit Care Med; 2020; 26(4):. PubMed ID: 34240037
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.
van Heerden JK; Louw EH; Thienemann F; Engel ME; Allwood BW
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232991
[TBL] [Abstract][Full Text] [Related]
11. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.
Meghji J; Lesosky M; Joekes E; Banda P; Rylance J; Gordon S; Jacob J; Zonderland H; MacPherson P; Corbett EL; Mortimer K; Squire SB
Thorax; 2020 Mar; 75(3):269-278. PubMed ID: 32102951
[TBL] [Abstract][Full Text] [Related]
12. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study.
Nightingale R; Chinoko B; Lesosky M; Rylance SJ; Mnesa B; Banda NPK; Joekes E; Squire SB; Mortimer K; Meghji J; Rylance J
Thorax; 2022 Nov; 77(11):1131-1139. PubMed ID: 34937802
[TBL] [Abstract][Full Text] [Related]
13. Does reduced lung diffusing capacity for carbon monoxide predict the presence of pulmonary hypertension?
Delcour KS; Singla A; Jarbou M; Alpert M; Dabbagh O
Am J Med Sci; 2010 Jul; 340(1):54-9. PubMed ID: 20463574
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit.
Jentzer JC; Wiley BM; Reddy YNV; Barnett C; Borlaug BA; Solomon MA
Eur Heart J Acute Cardiovasc Care; 2022 Mar; 11(3):230-241. PubMed ID: 35064269
[TBL] [Abstract][Full Text] [Related]
15. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic lupus.
Johnson SR; Gladman DD; Urowitz MB; Ibañez D; Granton JT
Lupus; 2004; 13(7):506-9. PubMed ID: 15352421
[TBL] [Abstract][Full Text] [Related]
17. Post-tuberculous lung function impairment in a tuberculosis reference clinic in Cameroon.
Mbatchou Ngahane BH; Nouyep J; Nganda Motto M; Mapoure Njankouo Y; Wandji A; Endale M; Afane Ze E
Respir Med; 2016 May; 114():67-71. PubMed ID: 27109813
[TBL] [Abstract][Full Text] [Related]
18. Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy.
Umar S; Partow-Navid R; Ruffenach G; Iorga A; Moazeni S; Eghbali M
Biol Sex Differ; 2017; 8():9. PubMed ID: 28344760
[TBL] [Abstract][Full Text] [Related]
19. Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study.
Nkereuwem E; Agbla S; Sallahdeen A; Owolabi O; Sillah AK; Genekah M; Tunkara A; Kandeh S; Jawara M; Saidy L; Bush A; Togun T; Kampmann B
Thorax; 2023 Mar; 78(3):281-287. PubMed ID: 36109164
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
